Deciphering Macrophage Phenotypes upon Lipid Uptake and Atherosclerosis

키워드

참고문헌 (140)

1. Gordon S, "Alternative activation of macrophages", Nat Rev Immunol, 3, pp.23~35 (2003)
2. Gautier EL, "Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages", Nat Immunol, 13, pp.1118~1128 (2012)
3. Shapouri-Moghaddam A, "Macrophage plasticity, polarization, and function in health and disease", J Cell Physiol, 233, pp.6425~6440 (2018)
4. Medzhitov R, "Origin and physiological roles of inflammation", Nature, 454, pp.428~435 (2008)
5. Wynn TA, "Macrophages in tissue repair, regeneration, and fibrosis", Immunity, 44, pp.450~462 (2016)
6. Nourshargh S, "Leukocyte migration into inflamed tissues", Immunity, 41, pp.694~707 (2014)
7. Epelman S, "Origin and functions of tissue macrophages", Immunity, 41, pp.21~35 (2014)
8. Davies LC, "Tissue-resident macrophages : then and now", Immunology, 144, pp.541~548 (2015)
9. Epelman S, "Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation", Immunity, 40, pp.91~104 (2014)
10. Jones CV, "Macrophages and CSF-1 : implications for development and beyond", Organogenesis, 9, pp.249~260 (2013)
11. Tabas I, "Monocyte-macrophages and t cells in atherosclerosis", Immunity, 47, pp.621~634 (2017)
12. Davies LC, "Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation", Nat Commun, 4, pp.1886~ (2013)
13. Bajpai G, "Tissue resident ccr2-and ccr2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury", Circ Res, 124, pp.263~278 (2019)
14. Liddiard K, "Macrophage heterogeneity and acute inflammation", Eur J Immunol, 41, pp.2503~2508 (2011)
15. Chawla A, "Macrophage-mediated inflammation in metabolic disease", Nat Rev Immunol, 11, pp.738~749 (2011)
16. Janeway CA Jr, "Innate immune recognition", Annu Rev Immunol, 20, pp.197~216 (2002)
17. Serhan CN, "Novel lipid mediators and resolution mechanisms in acute inflammation : to resolve or not", Am J Pathol, 177, pp.1576~1591 (2010)
18. Wang N, "Molecular mechanisms that influence the macrophage m1-m2 polarization balance", Front Immunol, 5, pp.614~ (2014)
19. Stienstra R, "Peroxisome proliferator-activated receptor gamma activation promotes infiltration of alternatively activated macrophages into adipose tissue", J Biol Chem, 283, pp.22620~22627 (2008)
20. Kurowska-Stolarska M, "IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation", J Immunol, 183, pp.6469~6477 (2009)
21. Lech M, "Macrophages and fibrosis : How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair", Biochim Biophys Acta, 1832, pp.989~997 (2013)
22. Patel U, "Macrophage polarization in response to epigenetic modifiers during infection and inflammation", Drug Discov Today, 22, pp.186~193 (2017)
23. Fujiu K, "Cardioprotective function of cardiac macrophages", Cardiovasc Res, 102, pp.232~239 (2014)
24. Lin SL, "Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations", J Immunol, 183, pp.6733~6743 (2009)
25. Lavin Y, "Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment", Cell, 159, pp.1312~1326 (2014)
26. Atri C, "Role of human macrophage polarization in inflammation during infectious diseases", Int J Mol Sci, 19, pp.19~ (2018)
27. Hansson GK, "The immune response in atherosclerosis : a double-edged sword", Nat Rev Immunol, 6, pp.508~519 (2006)
28. Bentzon JF, "Mechanisms of plaque formation and rupture", Circ Res, 114, pp.1852~1866 (2014)
29. Gerrity RG, "Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages", Am J Pathol, 95, pp.775~792 (1979)
30. Xu H, "Vascular macrophages in atherosclerosis", J Immunol Res, 2019, pp.4354786~ (2019)
31. Mestas J, "Monocyte-endothelial cell interactions in the development of atherosclerosis", Trends Cardiovasc Med, 18, pp.228~232 (2008)
32. Combadière C, "Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi)and Ly6C(lo)monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice", Circulation, 117, pp.1649~1657 (2008)
33. Tacke F, "Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques", J Clin Invest, 117, pp.185~194 (2007)
34. Goossens P, "Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions", Cell Metab, 12, pp.142~153 (2010)
35. Gerrity RG, "The role of the monocyte in atherogenesis : I. Transition of blood-borne monocytes into foam cells in fatty lesions", Am J Pathol, 103, pp.181~190 (1981)
36. Moore KJ, "Macrophages in the pathogenesis of atherosclerosis", Cell, 145, pp.341~355 (2011)
37. Ketelhuth DF, "Modulation of autoimmunity and atherosclerosis-common targets and promising translational approaches against disease", Circ J, 79, pp.924~933 (2015)
38. Ketelhuth DF, "Cellular immunity, low-density lipoprotein and atherosclerosis : break of tolerance in the artery wall", Thromb Haemost, 106, pp.779~786 (2011)
39. Wolf D, "Immunity and inflammation in atherosclerosis", Circ Res, 124, pp.315~327 (2019)
40. van der Wal AC, "Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology", Circulation, 89, pp.36~44 (1994)
41. Gerrity RG, "Lipid clearance from fatty streak lesions by foam cell migration", Artery, 8, pp.215~219 (1980)
42. Barrett TJ, "Macrophages in atherosclerosis regression", Arterioscler Thromb Vasc Biol, 40, pp.20~33 (2020)
43. Llodrá J, "Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques", Proc Natl Acad Sci U S A, 101, pp.11779~11784 (2004)
44. Boyle JJ, "Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype", Am J Pathol, 174, pp.1097~1108 (2009)
45. Boyle JJ, "Heme and haemoglobin direct macrophage Mhem phenotype and counter foam cell formation in areas of intraplaque haemorrhage", Curr Opin Lipidol, 23, pp.453~461 (2012)
46. Kadl A, "Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2", Circ Res, 107, pp.737~746 (2010)
47. Gleissner CA, "CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages", J Immunol, 184, pp.4810~4818 (2010)
48. Erbel C, "CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+ in vitro and in vivo", Innate Immun, 21, pp.255~265 (2015)
49. Gleissner CA, "CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages", Circ Res, 106, pp.203~211 (2010)
50. Chistiakov DA, "The role of monocytosis and neutrophilia in atherosclerosis", J Cell Mol Med, 22, pp.1366~1382 (2018)
51. van Gils JM, "Endothelial expression of guidance cues in vessel wall homeostasis dysregulation under proatherosclerotic conditions", Arterioscler Thromb Vasc Biol, 33, pp.911~919 (2013)
52. van Gils JM, "The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques", Nat Immunol, 13, pp.136~143 (2012)
53. Wanschel A, "Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention", Arterioscler Thromb Vasc Biol, 33, pp.886~893 (2013)
54. Qian YN, "Adhesion molecule CD146 and its soluble form correlate well with carotid atherosclerosis and plaque instability", CNS Neurosci Ther, 20, pp.438~445 (2014)
55. Luo Y, "Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis", Cell Res, 27, pp.352~372 (2017)
56. Moore KJ, "Macrophage trafficking, inflammatory resolution, and genomics in atherosclerosis : JACC macrophage in CVD series(part 2)", J Am Coll Cardiol, 72, pp.2181~2197 (2018)
57. Feig JE, "Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages", PLoS One, 6, pp.e28534~ (2011)
58. Wu C, "Modulation of macrophage gene expression via liver x receptor alpha serine 198 phosphorylation", Mol Cell Biol, 35, pp.2024~2034 (2015)
59. Gage MC, "Disrupting LXRα phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation", Proc Natl Acad Sci U S A, 115, pp.E6556~ (2018)
60. Feig JE, "Regression of atherosclerosis is characterized by broad changes in the plaque macrophage transcriptome", PLoS One, 7, pp.e39790~ (2012)
61. Wang Y, "Smooth muscle cells contribute the majority of foam cells in apoe(apolipoprotein e)-deficient mouse atherosclerosis", Arterioscler Thromb Vasc Biol, 39, pp.876~887 (2019)
62. Kim K, "Transcriptome analysis reveals nonfoamy rather than foamy plaque macrophages are proinflammatory in atherosclerotic murine models", Circ Res, 123, pp.1127~1142 (2018)
63. Cochain C, "Macrophages in vascular inflammation and atherosclerosis", Pflugers Arch, 469, pp.485~499 (2017)
64. Suzuki H, "A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection", Nature, 386, pp.292~296 (1997)
65. Moore KJ, "Macrophages in atherosclerosis : a dynamic balance", Nat Rev Immunol, 13, pp.709~721 (2013)
66. Brown MS, "A receptor-mediated pathway for cholesterol homeostasis", Science, 232, pp.34~47 (1986)
67. de Winther MP, "Macrophage scavenger receptor class A : a multifunctional receptor in atherosclerosis", Arterioscler Thromb Vasc Biol, 20, pp.290~297 (2000)
68. Endemann G, "CD36 is a receptor for oxidized low density lipoprotein", J Biol Chem, 268, pp.11811~11816 (1993)
69. Murphy JE, "Biochemistry and cell biology of mammalian scavenger receptors", Atherosclerosis, 182, pp.1~15 (2005)
70. Acton SL, "Expression cloning of SR-BI, a CD36-related class B scavenger receptor", J Biol Chem, 269, pp.21003~21009 (1994)
71. Acton S, "Identification of scavenger receptor SR-BI as a high density lipoprotein receptor", Science, 271, pp.518~520 (1996)
72. Brown AJ, "Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes", J Lipid Res, 41, pp.226~237 (2000)
73. Ouimet M, "Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase", Cell Metab, 13, pp.655~667 (2011)
74. Viaud M, "Lysosomal cholesterol hydrolysis couples efferocytosis to anti-inflammatory oxysterol production", Circ Res, 122, pp.1369~1384 (2018)
75. Chang TY, "Acyl-coenzyme A : cholesterol acyltransferase", Annu Rev Biochem, 66, pp.613~638 (1997)
76. de Winther MP, "Scavenging new insights into atherogenesis", J Clin Invest, 105, pp.1039~1041 (2000)
77. Glass CK, "Atherosclerosis. the road ahead", Cell, 104, pp.503~516 (2001)
78. Tall AR, "Cholesterol, inflammation and innate immunity", Nat Rev Immunol, 15, pp.104~116 (2015)
79. Stewart CR, "CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer", Nat Immunol, 11, pp.155~161 (2010)
80. Sheedy FJ, "CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation", Nat Immunol, 14, pp.812~820 (2013)
81. Duewell P, "NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals", Nature, 464, pp.1357~1361 (2010)
82. Kuida K, "Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme", Science, 267, pp.2000~2003 (1995)
83. Randolph GJ, "Mechanisms that regulate macrophage burden in atherosclerosis", Circ Res, 114, pp.1757~1771 (2014)
84. Sikorski K, "STAT1 as a central mediator of IFNγ and TLR4 signal integration in vascular dysfunction", JAK-STAT, 1, pp.241~249 (2012)
85. Chen Y, "Mitochondrial metabolic reprogramming by cd36 signaling drives macrophage inflammatory responses", Circ Res, 125, pp.1087~1102 (2019)
86. Dennis EA, "A mouse macrophage lipidome", J Biol Chem, 285, pp.39976~39985 (2010)
87. Spann NJ, "Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses", Cell, 151, pp.138~152 (2012)
88. Oh DY, "GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects", Cell, 142, pp.687~698 (2010)
89. Rios FJ, "Oxidized LDL induces alternative macrophage phenotype through activation of CD36 and PAFR", Mediators Inflamm, 2013, pp.198193~ (2013)
90. Butcher MJ, "Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta", Front Physiol, 3, pp.44~ (2012)
91. Goldstein JL, "Protein sensors for membrane sterols", Cell, 124, pp.35~46 (2006)
92. Horton JD, "SREBPs : activators of the complete program of cholesterol and fatty acid synthesis in the liver", J Clin Invest, 109, pp.1125~1131 (2002)
93. Bennett MK, "Sterol regulation of fatty acid synthase promoter. Coordinate feedback regulation of two major lipid pathways", J Biol Chem, 270, pp.25578~25583 (1995)
94. Ericsson J, "Identification of glycerol-3-phosphate acyltransferase as an adipocyte determination and differentiation factor 1-and sterol regulatory element-binding protein-responsive gene", J Biol Chem, 272, pp.7298~7305 (1997)
95. Lounis MA, "Oleate activates SREBP-1 signaling activity in SCD1-deficient hepatocytes", Am J Physiol Endocrinol Metab, 313, pp.E710~ (2017)
96. Moon YA, "Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins", J Biol Chem, 276, pp.45358~45366 (2001)
97. Im SS, "Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a", Cell Metab, 13, pp.540~549 (2011)
98. Oishi Y, "Srebp1 contributes to resolution of pro-inflammatory tlr4 signaling by reprogramming fatty acid metabolism", Cell Metab, 25, pp.412~427 (2017)
99. Schultz JR, "Role of LXRs in control of lipogenesis", Genes Dev, 14, pp.2831~2838 (2000)
100. Jongstra-Bilen J, "Oxidized low-density lipoprotein loading of macrophages downregulates tlr-induced proinflammatory responses in a gene-specific and temporal manner through transcriptional control", J Immunol, 199, pp.2149~2157 (2017)
101. Ito A, "LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling", eLife, 4, pp.e08009~ (2015)
102. Baardman J, "A defective pentose phosphate pathway reduces inflammatory macrophage responses during hypercholesterolemia", Cell Rep, 25, pp.2044~2052 (2018)
103. Emini Veseli B, "Animal models of atherosclerosis", Eur J Pharmacol, 816, pp.3~13 (2017)
104. Getz GS, "Animal models of atherosclerosis", Arterioscler Thromb Vasc Biol, 32, pp.1104~1115 (2012)
105. Meir KS, "Atherosclerosis in the apolipoprotein-E-deficient mouse : a decade of progress", Arterioscler Thromb Vasc Biol, 24, pp.1006~1014 (2004)
106. Piedrahita JA, "Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells", Proc Natl Acad Sci U S A, 89, pp.4471~4475 (1992)
107. Silvestre-Roig C, "Atherosclerotic plaque destabilization : mechanisms, models, and therapeutic strategies", Circ Res, 114, pp.214~226 (2014)
108. Ishibashi S, "Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice", J Clin Invest, 93, pp.1885~1893 (1994)
109. Maxwell KN, "Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype", Proc Natl Acad Sci U S A, 101, pp.7100~7105 (2004)
110. Rashid S, "Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9", Proc Natl Acad Sci U S A, 102, pp.5374~5379 (2005)
111. Roche-Molina M, "Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9", Arterioscler Thromb Vasc Biol, 35, pp.50~59 (2015)
112. Goettsch C, "A single injection of gain-of-function mutant PCSK9 adeno-associated virus vector induces cardiovascular calcification in mice with no genetic modification", Atherosclerosis, 251, pp.109~118 (2016)
113. Vozenilek AE, "AAV8-mediated overexpression of mPCSK9 in liver differs between male and female mice", Atherosclerosis, 278, pp.66~72 (2018)
114. Paigen B, "Quantitative assessment of atherosclerotic lesions in mice", Atherosclerosis, 68, pp.231~240 (1987)
115. Ji R, "Identifying macrophage enrichment in atherosclerotic plaques by targeting dual-modal US imaging", MRI based on biodegradable Fe-doped hollow silica nanospheres conjugated with anti-CD68 antibody, 2018, pp.10, 20246~20255
116. Lougheed M, "High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I", II, 1997, pp.272, 12938~12944
117. Feig JE, "Laser capture microdissection for analysis of macrophage gene expression from atherosclerotic lesions", Methods Mol Biol, 1027, pp.123~135 (2013)
118. Thomas AC, "Foam cell formation in vivo converts macrophages to a pro-fibrotic phenotype", PLoS One, 10, pp.e0128163~ (2015)
119. de Gaetano M, "M1-and m2-type macrophage responses are predictive of adverse outcomes in human atherosclerosis", Front Immunol, 7, pp.275~ (2016)
120. Jin X, "Culture of macrophage colony-stimulating factor differentiated human monocyte-derived macrophages", J Vis Exp, pp.54244~ (2016)
121. MacDonald C, "Development of new cell lines for animal cell biotechnology", Crit Rev Biotechnol, 10, pp.155~178 (1990)
122. Kaur G, "Cell lines : valuable tools or useless artifacts", Spermatogenesis, 2, pp.1~5 (2012)
123. Mäkinen PI, "Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors", Cardiovasc Res, 88, pp.530~538 (2010)
124. Qin Z, "The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature", Atherosclerosis, 221, pp.2~11 (2012)
125. Tsuchiya S, "Establishment and characterization of a human acute monocytic leukemia cell line(THP-1)", Int J Cancer, 26, pp.171~176 (1980)
126. Zhao YL, "Comparison of the characteristics of macrophages derived from murine spleen, peritoneal cavity, and bone marrow", J Zhejiang Univ Sci B, 18, pp.1055~1063 (2017)
127. Trouplin V, "Bone marrow-derived macrophage production", J Vis Exp, pp.e50966~ (2013)
128. Lavin Y, "Macrophages : gatekeepers of tissue integrity", Cancer Immunol Res, 1, pp.201~209 (2013)
129. 손모아, "Two Distinct Subsets Are Identified from the Peritoneal Myeloid Mononuclear Cells Expressing both CD11c and CD115", Immune Network, 19(3), pp.1~18 (2019), 대한면역학회
130. Ghosn EE, "Two physically, functionally, and developmentally distinct peritoneal macrophage subsets", Proc Natl Acad Sci U S A, 107, pp.2568~2573 (2010)
131. Yona S, "Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis", Immunity, 38, pp.79~91 (2013)
132. Hashimoto D, "Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes", Immunity, 38, pp.792~804 (2013)
133. Morrisey EE, "GATA-6 : a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm", Dev Biol, 177, pp.309~322 (1996)
134. Leijh PC, "Effect of thioglycolate on phagocytic and microbicidal activities of peritoneal macrophages", Infect Immun, 46, pp.448~452 (1984)
135. Meza-Perez S, "Immunological functions of the omentum", Trends Immunol, 38, pp.526~536 (2017)
136. Zhang N, "Expression of factor V by resident macrophages boosts host defense in the peritoneal cavity", J Exp Med, 216, pp.1291~1300 (2019)
137. Cassado AA, "Revisiting mouse peritoneal macrophages : heterogeneity, development, and function", Front Immunol, 6, pp.225~ (2015)
138. Winkels H, "Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass cytometry", Circ Res, 122, pp.1675~1688 (2018)
139. Cochain C, "Single-cell RNA-seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis", Circ Res, 122, pp.1661~1674 (2018)
140. Kim K, "Response by Kim and Choi to letter regarding article, "Transcriptome analysis reveals nonfoamy rather than foamy plaque macrophages are proinflammatory in atherosclerotic murine models"", Circ Res, 123, pp.e50~ (2018)

관련 논문AI추천